HiNF-P is a bifunctional regulator of cell cycle controlled histone H4 gene transcription

Journal of Cellular Biochemistry

Volumn 101, Issue 1, 2007, Pages 181-191

  Mitra, Partha ^a   Xie, Ronglin ^a   Harper, J Wade ^b   Stein, Janet L ^a   Stein, Gary S ^a   Van Wijnen, Andre J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CDK inhibitor; Cell cycle; HiNF P; Histone; KIP2; NPAT; p57; Transcription factor

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1C; HISTONE H4; NUCLEAR FACTOR; NUCLEAR PROTEIN; PROTEIN P220 NPAT; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR HINF P; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CONTROLLED STUDY; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE REPRESSION; H4 GENE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN-DEPENDENT KINASE INHIBITOR P57; GENES, REPORTER; HELA CELLS; HISTONES; HUMANS; LUCIFERASES; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; TRANSFECTION;

ATAXIA TELANGIECTASIA;

EID: 34247517360     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21157     Document Type: Article

References (62)

1. Arai S, Miyazaki T. 2005. Impaired maturation of myeloid progenitors in mice lacking novel Polycomb group protein MBT-1. EMBO J 24:1863-1873.
2. Aziz F, van Wijnen AJ, Stein JL, Stein GS. 1998a. HiNF-D (CDP-cut/CDC2/cyclin A/pRB-complex) influences the timing of IRF-2 dependent cell cycle activation of human histone H4 gene transcription at the G1/S phase transition. J Cell Physiol 177:453-464.
3. Aziz F, van Wijnen AJ, Vaughan PS, Wu S, Shakoori AR, Lian JB, Soprano KJ, Stein JL, Stein GS. 1998b. The integrated activities of IRF-2 (HiNF-M) CDP/cut (HiNF-D) and H4TF-2 (HiNF-P) regulate transcription of a cell cycle controlled human histone H4 gene: Mechanistic differences between distinct H4 genes. Mol Biol Rep 25:1-12.
4. Berthet C, Aleem E, Coppola V, Tessarollo L, Kaldis P. 2003. Cdk2 knockout mice are viable. Curr Biol 13:1775-1785.
5. Birnbaum MJ, van Wijnen AJ, Odgren PR, Last TJ, Suske G, Stein GS, Stein JL. 1995a. Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. Biochemistry 34:16503-16508.
6. Birnbaum MJ, Wright KL, van Wijnen AJ, Ramsey-Ewing AL, Bourke MT, Last TJ, Aziz F, Frenkel B, Rao BR, Aronin N, Stein GS, Stein JL. 1995b. Functional role for Sp1 in the transcriptional amplification of a cell cycle regulated histone H4 gene. Biochemistry 34:7648-7658.
7. Di Fruscio M, Weiher H, Vanderhyden BC, Imai T, Shiomi T, Hori TA, Jaenisch R, Gray DA. 1997. Proviral inactivation of the Npat gene of Mpv 20 mice results in early embryonic arrest. Mol Cell Biol 17:4080-4086.
8. Dimova DK, Dyson NJ. 2005. The E2F transcriptional network: Old acquaintances with new faces. Oncogene 24:2810-2826.
9. Dominski Z, Marzluff WF. 1999. Formation of the 3′ end of histone mRNA. Gene 239:1-14.
10. Dyson N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev 12:2245-2262.
11. Guo B, Stein JL, van Wijnen AJ, Stein GS. 1997. ATF1 and CREB trans-activate a cell cycle regulated histone H4 gene at a distal nuclear matrix associated promoter element. Biochemistry 36:14447-14455.
12. Gupta S, Luong MX, Bleuming SA, Miele A, Luong M, Young D, Knudsen ES, van Wijnen AJ, Stein JL, Stein GS. 2003. The tumor suppressor pRB functions as a corepressor of the CCAAT displacement protein (CDP/cut) to regulate cell cycle controlled histone H4 transcription. J Cell Physiol 196:541-546.
13. Hatada I, Ohashi H, Fukushima Y, Kaneko Y, Inoue M, Komoto Y, Okada A, Ohishi S, Nabetani A, Morisaki H, Nakayama M, Niikawa N, Mukai T. 1996. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat Genet 14:171-173.
14. Hoffmann MJ, Florl AR, Seifert HH, Schulz WA. 2005. Multiple mechanisms downregulate CDKN1C in human bladder cancer. Int J Cancer 114:406-413.
15. Holmes WF, Braastad CD, Mitra P, Hampe C, Doenecke D, Albig W, Stein JL, van Wijnen AJ, Stein GS. 2005. Coordinate control and selective expression of the full complement of replication-dependent histone H4 genes in normal and cancer cells. J Biol Chem 280:37400-37407.
16. Holthuis J, Owen TA, van Wijnen AJ, Wright KL, Ramsey-Ewing A, Kennedy MB, Carter R, Cosenza SC, Soprano KJ, Lian JB, et al. 1990. Tumor cells exhibit deregulation of the cell cycle histone gene promoter factor HiNF-D. Science 247:1454-1457.
17. Hovhannisyan H, Cho B, Mitra P, Montecino M, Stein GS, van Wijnen AJ, Stein JL. 2003. Maintenance of open chromatin and selective genomic occupancy at the cell-cycle-regulated histone H4 promoter during differentiation of HL-60 promyelocytic leukemia cells. Mol Cell Biol 23:1460-1469.
18. Jensen DE, Black AR, Swick AG, Azizkhan JC. 1997. Distinct roles for Sp1 and E2F sites in the growth/cell cycle regulation of the DHFR promoter. J Cell Biochem 67:24-31.
19. Kikuchi T, Toyota M, Itoh F, Suzuki H, Obata T, Yamamoto H, Kakiuchi H, Kusano M, Issa JP, Tokino T, Imai K. 2002. Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors. Oncogene 21:2741-2749.
20. Kobatake T, Yano M, Toyooka S, Tsukuda K, Dote H, Kikuchi T, Toyota M, Ouchida M, Aoe M, Date H, Pass HI, Doihara H, Shimizu N. 2004. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas. Oncol Rep 12:1087-1092.
21. Kondo M, Matsuoka S, Uchida K, Osada H, Nagatake M, Takagi K, Harper JW, Takahashi T, Elledge SJ, Takahashi T. 1996. Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5. Oncogene 12:1365-1368.
22. Kroeger P, Stewart C, Schaap T, van Wijnen A, Hirshman J, Helms S, Stein G, Stein J. 1987. Proximal and distal regulatory elements that influence in vivo expression of a cell cycle-dependent human H4 histone gene. Proc Natl Acad Sci USA 84:3982-3986.
23. Last TJ, van Wijnen AJ, Birnbaum MJ, Stein GS, Stein JL. 1999. Multiple interactions of the transcription factor YY1 with human histone H4 gene regulatory elements. J Cell Biochem 72:507-516.
24. Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H. 2005. Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 65:4218-4227.
25. Ma T, Van Tine BA, Wei Y, Garrett MD, Nelson D, Adams PD, Wang J, Qin J, Chow LT, Harper JW. 2000. Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription. Genes Dev 14:2298-2313.
26. Martin A, Odajima J, Hunt SL, Dubus P, Ortega S, Malumbres M, Barbacid M. 2005. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1). Cancer Cell 7:591-598.
27. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ. 1995. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9:650-662.
28. Miele A, Braastad CD, Holmes WF, Mitra P, Medina R, Xie R, Zaidi SK, Ye X, Wei Y, Harper JW, van Wijnen AJ, Stein JL, Stein GS. 2005. HiNF-P directly links the cyclin E/CDK1/p220NPAT pathway to histone H4 gene regulation at the G1/S phase cell cycle transition. Mol Cell Biol 25:6140-6153.
29. Mitra P, Xie RL, Medina R, Hovhannisyan H, Zaidi SK, Wei Y, Harper JW, Stein JL, van Wijnen AJ, Stein GS. 2003. Identification of HiNF-P, a key activator of cell cycle controlled histone H4 genes at the onset of S phase. Mol Cell Biol 23:8110-8123.
30. Morris TD, Weber LA, Hickey E, Stein GS, Stein JL. 1991. Changes in the stability of a human H3 histone mRNA during the HeLa cell cycle. Mol Cell Biol 11:544-553.
31. Nevins JR. 2001. The Rb/E2F pathway and cancer. Hum Mol Genet 10:699-703.
32. Nishimori S, Tanaka Y, Chiba T, Fujii M, Imamura T, Miyazono K, Ogasawara T, Kawaguchi H, Igarashi T, Fujita T, Tanaka K, Toyoshima H. 2001. Smad-mediated transcription is required for transforming growth factor-beta 1-induced p57(Kip2) proteolysis in osteoblastic cells. J Biol Chem 276:10700-10705.
33. Orlow I, Iavarone A, Crider-Miller SJ, Bonilla F, Latres E, Lee MH, Gerald WL, Massague J, Weissman BE, Cordon-Cardo C. 1996. Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors. Cancer Res 56:1219-1221.
34. Palombella VJ, Maniatis T. 1992. Inducible processing of interferon regulatory factor-2. Mol Cell Biol 12:3325-3336.
35. Pauli U, Chrysogelos S, Stein G, Stein J, Nick H. 1987. Protein-DNA interactions in vivo upstream of a cell cycle-regulated human H4 histone gene. Science 236:1308-1311.
36. Peltz SW, Brewer G, Groppi V, Ross J. 1989. Exonuclease activity that degrades histone mRNA is stable when DNA or protein synthesis is inhibited. Mol Biol Med 6:227-238.
37. Ramsey-Ewing A, van Wijnen AJ, Stein GS, Stein JL. 1994. Delineation of a human histone H4 cell cycle element in vivo: The master switch for H4 gene transcription. Proc Natl Acad Sci USA 91:4475-4479.
38. Scandura JM, Boccuni P, Massague J, Nimer SD. 2004. Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc Natl Acad Sci USA 101:15231-15236.
39. Sekimata M, Homma Y. 2004. Sequence-specific transcriptional repression by an MBD2-interacting zinc finger protein MIZF. Nucleic Acids Res 32:590-597.
40. Sekimata M, Takahashi A, Murakami-Sekimata A, Homma Y. 2001. Involvement of a novel zinc finger protein, MIZF, in transcriptional repression by interacting with a methyl-CpG-binding protein, MBD2. J Biol Chem 276:42632-42638.
41. Stein GS, Stein JL, Marzluff WF. 1984. Histone Genes. New York: John Wiley & Sons, Inc.
42. Stein G, Lian J, Stein J, Briggs R, Shalhoub V, Wright K, Pauli U, van Wijnen A. 1989. Altered binding of human histone gene transcription factors during the shutdown of proliferation and onset of differentiation in HL-60 cells. Proc Natl Acad Sci USA 86:1865-1869.
43. Stein GS, Stein JL, van Wijnen AJ, Lian JB. 1992. Regulation of histone gene expression. Curr Opin Cell Biol 4:166-173.
44. Stein GS, Stein JL, van Wijnen AJ, Lian JB. 1996. Transcriptional control of cell cycle progression: The histone gene is a paradigm for the G1/S phase and proliferation/differentiation transitions. Cell Biol Int 20:41-49.
45. Tokino T, Urano T, Furuhata T, Matsushima M, Miyatsu T, Sasaki S, Nakamura Y. 1996. Characterization of the human p57KIP2 gene: Alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis. Hum Genet 97:625-631.
46. Truscott M, Raynal L, Premdas P, Goulet B, Leduy L, Berube G, Nepveu A. 2003. CDP/Cux Stimulates Transcription from the DNA Polymerase alpha Gene Promoter. Mol Cell Biol 23:3013-3028.
47. Truscott M, Raynal L, Wang Y, Berube G, Leduy L, Nepveu A. 2004. The N-terminal region of the CCAAT displacement protein (CDP)/Cux transcription factor functions as an autoinhibitory domain that modulates DNA binding. J Biol Chem 279:49787-49794.
48. van den Ent FM, van Wijnen AJ, Last TJ, Bortell R, Stein JL, Lian JB, Stein GS. 1993. Concerted control of multiple histone promoter factors during cell density inhibition of proliferation in osteosarcoma cells: Reciprocal regulation of cell cycle-controlled and bone-related genes. Cancer Res 53:2399-2409.
49. van der Meijden CMJ, Vaughan PS, Staal A, Albig W, Doenecke D, Stein JL, Stein GS, van Wijnen AJ. 1998. Selective expression of specific histone H4 genes reflects distinctions in transcription factor interactions with divergent H4 promoter elements. Biochim Biophys Acta 1442:82-100.
50. van Wijnen AJ, Wright KL, Lian JB, Stein JL, Stein GS. 1989. Human H4 histone gene transcription requires the proliferation- specific nuclear factor HiNF-D. Auxiliary roles for HiNF-C (Sp1- like) and HiNF-A (high mobility group-like). J Biol Chem 264:15034-15042.
51. van Wijnen AJ, Ramsey-Ewing AL, Bortell R, Owen TA, Lian JB, Stein JL, Stein GS. 1991. Transcriptional element H4-site II of cell cycle regulated human H4 histone genes is a multipartite protein/DNA interaction site for factors HiNF-D, HiNF-M, and HiNF-P: Involvement of phosphorylation. J Cell Biochem 46:174-189.
52. van Wijnen AJ, van den Ent FM, Lian JB, Stein JL, Stein GS. 1992. Overlapping and CpG methylation-sensitive protein-DNA interactions at the histone H4 transcriptional cell cycle domain: Distinctions between two human H4 gene promoters. Mol Cell Biol 12:3273-3287.
53. van Wijnen AJ, Aziz F, Grana X, De LA, Desai RK, Jaarsveld K, Last TJ, Soprano K, Giordano A, Lian JB, Stein JL, Stein GS. 1994. Transcription of histone H4, H3, and H1 cell cycle genes: Promoter factor HiNF-D contains CDC2, cyclin A, and an RB-related protein. Proc Natl Acad Sci USA 91:12882-12886.
54. van Wijnen AJ, van Gurp MF, de Ridder MC, Tufarelli C, Last TJ, Birnbaum M, Vaughan PS, Giordano A, Krek W, Neufeld EJ, Stein JL, Stein GS. 1996. CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: A mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2F. Proc Natl Acad Sci USA 93:11516-11521.
55. Vaughan PS, Aziz F, van Wijnen AJ, Wu S, Harada H, Taniguchi T, Soprano KJ, Stein JL, Stein GS. 1995. Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2. Nature 377:362-365.
56. Vaughan PS, van der Meijden CMJ, Aziz F, Harada H, Taniguchi T, van Wijnen AJ, Stein JL, Stein GS. 1998. Cell cycle regulation of histone H4 gene transcription requires the oncogenic factor IRF-2. J Biol Chem 273:194-199.
57. Wei Y, Jin J, Harper JW. 2003. The cyclin E/Cdk2 substrate and Cajal body component p220(NPAT) activates histone transcription through a novel LisH-like domain. Mol Cell Biol 23:3669-3680.
58. Xie R, van Wijnen AJ, van der Meijden CMJ, Luong MX, Stein JL, Stein GS. 2001. The cell cycle control element of histone H4 gene transcription is maximally responsive to interferon regulatory factor pairs IRF-1/TRF-3 and IRF-1/IRF-7. J Biol Chem 276:18624-18632.
59. Ye X, Wei Y, Nalepa G, Harper JW. 2003. The cyclin E/Cdk2 substrate p220(NPAT) is required for S-phase entry, histone gene expression, and Cajal body maintenance in human somatic cells. Mol Cell Biol 23:8586-8600.
60. Zhang P, Liégeois NJ, Wong C, Finegold M, Hou H, Thompson JC, Silverman A, Harper JW, DePinho RA, Elledge SJ. 1997. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387:151-158.
61. Zhao J, Dynlacht B, Imai T, Hori T, Harlow E. 1998. Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Genes Dev 12:456-461.
62. Zhao J, Kennedy BK, Lawrence BD, Barbie DA, Matera AG, Fletcher JA, Harlow E. 2000. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev 14:2283-2297.